Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

L‐Carnitine Suppresses Loss of Skeletal Muscle Mass in Patients With Liver Cirrhosis
Masatsugu Ohara, Koji Ogawa, Goki Suda, et al.
Hepatology Communications (2018) Vol. 2, Iss. 8, pp. 910-922
Open Access | Times Cited: 77

Showing 1-25 of 77 citing articles:

Malnutrition, Frailty, and Sarcopenia in Patients With Cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases
Jennifer C. Lai, Puneeta Tandon, William Bernal, et al.
Hepatology (2021) Vol. 74, Iss. 3, pp. 1611-1644
Open Access | Times Cited: 431
A North American Expert Opinion Statement on Sarcopenia in Liver Transplantation
Elizabeth J. Carey, Jennifer C. Lai, Christopher J. Sonnenday, et al.
Hepatology (2019) Vol. 70, Iss. 5, pp. 1816-1829
Open Access | Times Cited: 202
Molecular Mechanisms of Inflammation in Sarcopenia: Diagnosis and Therapeutic Update
Guadalupe Elizabeth Jiménez-Gutiérrez, Laura E. Martínez-Gómez, Carlos Martínez-Armenta, et al.
Cells (2022) Vol. 11, Iss. 15, pp. 2359-2359
Open Access | Times Cited: 101
Clinical impact of sarcopenia assessment in patients with hepatocellular carcinoma undergoing treatments
Giovanni Marasco, Matteo Serenari, Matteo Renzulli, et al.
Journal of Gastroenterology (2020) Vol. 55, Iss. 10, pp. 927-943
Open Access | Times Cited: 87
Skeletal Muscle Mass Influences Tolerability and Prognosis in Hepatocellular Carcinoma Patients Treated with Lenvatinib
Haruki Uojima, Makoto Chuma, Yoshiaki Tanaka, et al.
Liver Cancer (2019) Vol. 9, Iss. 2, pp. 193-206
Open Access | Times Cited: 77
Sarcopenia in hepatocellular carcinoma: Current knowledge and future directions
Abhilash Perisetti, Hemant Goyal, Rachana Yendala, et al.
World Journal of Gastroenterology (2022) Vol. 28, Iss. 4, pp. 432-448
Open Access | Times Cited: 54
Emerging awareness on the importance of skeletal muscle in liver diseases: time to dig deeper into mechanisms!
Maxime Nachit, Isabelle Leclercq
Clinical Science (2019) Vol. 133, Iss. 3, pp. 465-481
Closed Access | Times Cited: 63
Usefulness of Carnitine Supplementation for the Complications of Liver Cirrhosis
Tatsunori Hanai, Makoto Shiraki, Kenji Imai, et al.
Nutrients (2020) Vol. 12, Iss. 7, pp. 1915-1915
Open Access | Times Cited: 50
Evaluation and Management of Nutritional Consequences of Chronic Liver Diseases
Silvia Espina, Diego Casas Deza, Vanesa Bernal Monterde, et al.
Nutrients (2023) Vol. 15, Iss. 15, pp. 3487-3487
Open Access | Times Cited: 22
Pathophysiological-Based Nutritional Interventions in Cirrhotic Patients with Sarcopenic Obesity: A State-of-the-Art Narrative Review
Ernestina Santangeli, Chiara Abbati, Rusi Chen, et al.
Nutrients (2024) Vol. 16, Iss. 3, pp. 427-427
Open Access | Times Cited: 6
N-acetyl cysteine treatment mitigates biomarkers of oxidative stress in different tissues of bile duct ligated rats
Mohammad Mehdi Ommati, Ali Amjadinia, Khadijeh Mousavi, et al.
Stress (2020) Vol. 24, Iss. 2, pp. 213-228
Open Access | Times Cited: 41
Sarcopenia and Frailty in Liver Cirrhosis
Hiroki Nishikawa, Shinya Fukunishi, Akira Asai, et al.
Life (2021) Vol. 11, Iss. 5, pp. 399-399
Open Access | Times Cited: 35
Osteosarcopenia in NAFLD/MAFLD: An Underappreciated Clinical Problem in Chronic Liver Disease
Alessandra Musio, Federica Perazza, Laura Leoni, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7517-7517
Open Access | Times Cited: 15
Liver Cirrhosis and Sarcopenia from the Viewpoint of Dysbiosis
Hiroki Nishikawa, Hirayuki Enomoto, Shuhei Nishiguchi, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 15, pp. 5254-5254
Open Access | Times Cited: 39
Prevalence, clinical course, and predictive factors of immune checkpoint inhibitor monotherapy‐associated hepatitis in Japan
Takashi Kitagataya, Goki Suda, Kazunori Nagashima, et al.
Journal of Gastroenterology and Hepatology (2020) Vol. 35, Iss. 10, pp. 1782-1788
Closed Access | Times Cited: 37
Analysis of the optimal psoas muscle mass index cut‐off values, as measured by computed tomography, for the diagnosis of loss of skeletal muscle mass in Japanese people
Masatsugu Ohara, Goki Suda, Megumi Kimura, et al.
Hepatology Research (2020) Vol. 50, Iss. 6, pp. 715-725
Closed Access | Times Cited: 36
Influencing Factors and Molecular Pathogenesis of Sarcopenia and Osteosarcopenia in Chronic Liver Disease
Chisato Saeki, Akihito Tsubota
Life (2021) Vol. 11, Iss. 9, pp. 899-899
Open Access | Times Cited: 27
Sarcopenia and Frailty in Cirrhosis
Chalermrat Bunchorntavakul
Medical Clinics of North America (2023) Vol. 107, Iss. 3, pp. 589-604
Closed Access | Times Cited: 11
Diagnostic and Prognostic Value of Hyperammonemia in Patients with Liver Cirrhosis, Hepatic Encephalopathy, and Sarcopenia (Experts’ Agreement)
M. Yu. Nadinskaia, M. V. Maevskaya, И. Г. Бакулин, et al.
Russian Journal of Gastroenterology Hepatology Coloproctology (2024) Vol. 34, Iss. 1, pp. 85-100
Open Access | Times Cited: 4
Intestinal-Failure-Associated Liver Disease: Beyond Parenteral Nutrition
Irene Mignini, Giulia Piccirilli, Federica Di Vincenzo, et al.
Biomolecules (2025) Vol. 15, Iss. 3, pp. 388-388
Open Access
Comprehensive review of the expanding roles of the carnitine pool in metabolic physiology: beyond fatty acid oxidation
Feng Xiang, Zhimin Zhang, Jingchen Xie, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Relationship between daily physical activity and muscle cramping in elderly liver cirrhosis patients-A multicenter study
Atsushi Hiraoka, Tadashi Namisaki, Masato Nakai, et al.
Internal Medicine (2025)
Open Access
Effects of Pemafibrate on Serum Carnitine and Plasma Myostatin in Patients With Metabolic Dysfunction Associated Steatotic Liver Disease
Ryohei Tanigawa, Atsushi Nakajima, Yuichiro Eguchi, et al.
Deleted Journal (2025) Vol. 8, Iss. 1
Open Access
Pharmacotherapy for Cirrhosis in Japan
Hiroki Nishikawa, Soo Ki Kim, Akira Asai
Portal hypertension & cirrhosis (2025)
Open Access
Interventions to improve sarcopenia in cirrhosis: A systematic review
Maliha Naseer, Erica P. Turse, Ali Syed, et al.
World Journal of Clinical Cases (2019) Vol. 7, Iss. 2, pp. 156-170
Open Access | Times Cited: 32
Page 1 - Next Page

Scroll to top